Developing antiviral agents for treating COVID-19 patients, this discovery will stimulate the opening of a new avenue in therapeutics directed at the SARS virus
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free